Weather , , 0°C

Retinal Vein Occlusion Market is Expected to Expand at a Healthy Growth Rate by 2030 | Key Companies includes – Panoptes, Graybug, Merck, Genentech, Regeneron and Others

 Breaking News
  • No posts were found

Retinal Vein Occlusion Market is Expected to Expand at a Healthy Growth Rate by 2030 | Key Companies includes – Panoptes, Graybug, Merck, Genentech, Regeneron and Others

September 15
22:16 2021
Retinal Vein Occlusion Market is Expected to Expand at a Healthy Growth Rate by 2030 | Key Companies includes - Panoptes, Graybug, Merck, Genentech, Regeneron and Others
Delveinsight Business Research LLP
DelveInsight’s “Retinal Vein Occlusion Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Retinal Vein Occlusion Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Retinal Vein Occlusion market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Retinal Vein Occlusion Market

Retinal Vein Occlusion: An Overview

Retinal vein occlusion (RVO) is an interruption of the normal venous drainage from the retinal tissue. Either the central vein or one of its branches can become occluded. Uncommonly, the occlusion can occur in a vein that drains half of the retina. This is referred to as a hemi-retinal vein occlusion (HRVO).

There’s no medication available that’s specific for retinal artery occlusions. Most people with this condition will have permanent changes to their vision.

Retinal Vein Occlusion Market Key Facts

  • Retinal vein occlusion is a common cause of sudden, painless reduction or loss of vision in older people (it is uncommon in people under the age of 60). It occurs when an artery presses on and blocks one of the veins in the retina (the thin lining at the back of the eye that allows us to see). 

  • As per the study conducted by Li et al., the prevalence of Retinal Vein Occlusion in Europe was found to be 0.7% in persons aged 55 years and older based on the examination of individuals from four prevalence studies.

  • According to the study conducted by Kolar et al., RVO is more prevalent in men than women and is more frequent in older age (over 65 years).

Get FREE sample copy at:

Key Benefits of Retinal Vein Occlusion Market Report

  • The report provides an in-depth analysis of Retinal Vein Occlusion Market Size and Share till 2030 in the seven major markets.

  • The report will help in developing business strategies by understanding the Retinal Vein Occlusion Market Trends, key players, and ongoing developments that shape and drive the market growth in the upcoming years.

  • It covers Retinal Vein Occlusion current treatment practices, emerging drugs, market share of the individual therapies in the 7MM.

  • The report provides a detailed assessment of the Retinal Vein Occlusion market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Retinal Vein Occlusion Market

Currently, there is no treatment that can reverse the blocked vein. The aims of treatment are to detect and treat any underlying risk factors for Retinal Vein Occlusion (RVO) and also to detect and treat any complications where possible.

As per DelveInsight, the Retinal vein occlusion (RVO) market size shall grow during the forecast period owing to the launch of upcoming therapies.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Retinal Vein Occlusion market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

The report gives a thorough detail of the Retinal Vein Occlusion market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Request for Sample @ Retinal Vein Occlusion Therapeutics Market Assessment

Retinal Vein Occlusion Epidemiology

The epidemiology section covers insights about the historical and current Retinal Vein Occlusion patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Retinal Vein Occlusion Epidemiology Segmentation

  • Total Prevalent Cases of Retinal Vein Occlusion 

  • Gender-Specific Prevalent Cases of Retinal Vein Occlusion

  • Diagnosed and Treatable Cases of Retinal Vein Occlusion

  • Type-Specific Prevalent Cases of Retinal Vein Occlusion

  • Age-Specific Prevalent Cases of Retinal Vein Occlusion

Retinal Vein Occlusion Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Retinal Vein Occlusion market or expected to get launched in the market during the study period. The analysis covers Retinal Vein Occlusion market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Retinal Vein Occlusion Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Some of the key companies in the Retinal Vein Occlusion market include:

  • Panoptes Pharma

  • Outlook Therapeutics

  • Graybug Vision

  • Merck

  • Genentech

  • Regeneron

  • Allergan

  • Kodiak Sciences

And many others

Retinal Vein Occlusion Therapies covered in the report includes:

  • PaniJect

  • ONS-5010

  • GB-102

  • KSI-301

And many others.

Table of Content

1. Key Insights

2. Executive Summary 

3. Retinal Vein Occlusion Competitive Intelligence Analysis

4. Retinal Vein Occlusion Market Overview at a Glance

5. Retinal Vein Occlusion Disease Background and Overview

6. Retinal Vein Occlusion Patient Journey

7. Retinal Vein Occlusion Epidemiology and Patient Population

8. Retinal Vein Occlusion Treatment Algorithm, Current Treatment, and Medical Practices

9. Retinal Vein Occlusion Unmet Needs

10. Key Endpoints of Retinal Vein Occlusion Treatment

11. Retinal Vein Occlusion Marketed Products

12. Retinal Vein Occlusion Emerging Therapies

13. Retinal Vein Occlusion Seven Major Market Analysis

14. Attribute Analysis

15. Retinal Vein Occlusion Market Outlook (7 major markets)

16. Retinal Vein Occlusion Access and Reimbursement Overview

17. KOL Views on the Retinal Vein Occlusion Market.

18. Retinal Vein Occlusion Market Drivers

19. Retinal Vein Occlusion Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at:

Latest Reports By DelveInsight

Retinal Vein Occlusion Pipeline Insights

Retinal Vein Occlusion Pipeline Insight, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Retinal Vein Occlusion market.


About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.


Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States

Related Articles


October 2021